insider24.ch
Back to the feed

Shareholding disclosure

Santhera Pharmaceuticals Holding AG

inSanthera Pharmaceuticals Holding AG

Declared position

72.83%

Threshold

Crossed downwards

Timeline

Published

24.06.2023

Transaction

19.06.2023

Voting rights breakdown

Voting rights acquired16.55%
Voting rights sold72.83%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAN6N000K5

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

Das Datum der Aktienübertragung ist derzeit unbekannt. Regarding certain sale positions

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open